September 23, 2013

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2013 ACS

Patent Number: WO 2013096093
Title: Preparation of triazolylpyridine derivatives and analogs for use as DGAT-1 inhibitors
Inventor(s): Devita, Robert J.; He, Shuwen; Liu, Jian; Cernak, Timothy A.; Krikorian, Arto D.; Yang, Ginger Xuqiang; Wu, Zhicai; Yu, Yang; Shen, Dong-Ming; Lai, Zhong; Hong, Qingmei; Nargund, Ravi P.
Patent Assignee(s): Merck Sharp & Dohme Corp., USA
Source: PCT Int. Appl., 119pp. CODEN: PIXXD2
Language: English

Abstract:
Title compds. I [T = bond or O; U = (un)substituted Ph, pyridinyl, pyrimidinyl, etc.; V and X independently = CH or N; Y and Z independently = N, CH, or CR2; R1 = alkoxy, (un)substituted pyridinyl, cyclohexanyl, etc.; R2 = (un)substituted alkyl, Ph, cycloalkyl, etc.; R3 = halo, CN, alkyl or alkoxy and is optionally present at one of more of the ring carbons; provided at least one X, Y, or Z is N], and their pharmaceutically acceptable salts, are prepd. and disclosed as DGAT-1 inhibitors.  Thus, e.g., II was prepd. by a multistep procedure (prepn. given).  Select I were evaluated in hDGAT1 assays (data given).

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 View the full-text here.

Recent News


    June 29, 2015 | CAS Assigns the 100 Millionth CAS
    Registry Number to a Substance Designed to
    Treat Acute Myeloid Leukemia
   
    March 17, 2015 | New Content Provides Regulatory
    Professionals with Additional Value

    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals

                                                                       More News >> 
 
 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org